Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Seroquel in Bipolar Depression Versus Lithium [Phase 3]
A Phase 3 study comparing quetiapine (Seroquel) to lithium in bipolar depression has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Study of Antidepressants in Parkinson's Disease [Phase 3]
Phase 3 trial evaluating antidepressants in Parkinson's disease has completed and the results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Seroquel in Bipolar Depression Versus SSRI [Phase 3]
A Phase 3 trial evaluating quetiapine (Seroquel) for bipolar depression, comparing it to an SSRI, has completed.
-
CLINICAL_TRIALS research · 2013-01-04Clinical Trial Update: A Randomized Sham-Controlled Study of H-Coil Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Late-Life Depression [NA]
This document describes a randomized, sham-controlled study of H-Coil repetitive transcranial magnetic stimulation for treatment-resistant l…
-
FDA approval · 2013-01-03FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression [NA]
This update reports results on the safety and effectiveness of S-adenosyl-L-methionine (SAMe) for the treatment of major depressive disorder…
-
FDA label_change · 2012-12-21FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for VIIBRYD (vilazodone hydrochloride). The action is related to updates to the drug's …
-
FDA approval · 2012-12-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-12-18FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2012-12-18FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Primary Care Patients With Depression for Internet-Based Social Support [Phase 1, Phase 2]
Completed Phase 1 and Phase 2 trials evaluating internet-based social support for primary care patients with depression.
-
CLINICAL_TRIALS withdrawal · 2012-12-17Clinical Trial Update: Primary Care Internet-Based Depression Prevention for Adolescents (CATCH-IT) [Phase 3]
Phase 3 clinical trial of the internet-based depression prevention program CATCH-IT for adolescents has been withdrawn.
-
FDA approval · 2012-12-14FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Viibryd (vilazodone hydrochloride) submitted by Allergan, Inc., reflecting an approved updat…
-
CLINICAL_TRIALS withdrawal · 2012-12-13Clinical Trial Update: Major Depressive Disorder With Mixed Features [Phase 3]
A Phase 3 clinical trial for Major Depressive Disorder with mixed features has been withdrawn.
-
FDA approval · 2012-12-11FDA Approved: REMERON — Supplemental Application (Organon LLC)
FDA approves a supplemental application for REMERON (mirtazapine) submitted by Organon LLC.
-
FDA approval · 2012-12-11FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, expanding the drug’s approved …
-
CLINICAL_TRIALS withdrawal · 2012-12-11Clinical Trial Update: Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder [Phase 2]
A Phase 2 randomized, placebo-controlled trial of an AMPAkine for major depressive disorder was withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Yoga in Unipolar and Bipolar Disorders [NA]
A completed clinical trial evaluated yoga as an intervention for bipolar disorder and depressive disorders, including major depressive disor…
-
FDA approval · 2012-12-03FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for Celexa (citalopram) under NDA 020822.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning [Phase 3]
Phase 3 trial evaluating the impact of galantamine hydrobromide as an adjunct to electroconvulsive therapy on mood and cognitive outcomes in…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer [Phase 3]
Phase 3 trial evaluating escitalopram for depression in patients with advanced lung or gastrointestinal cancer was terminated; results were …
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Biobehavioral Bases & Management of Type 2 Diabetes [NA]
A completed clinical trial from the University of Miami examined biobehavioral factors and management approaches for individuals with Type 2…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Effects of Testosterone in Women With Depression [NA]
A completed clinical trial evaluating the effects of testosterone treatment in women with depression. Results were posted in 2012.
-
CLINICAL_TRIALS research · 2012-11-22Clinical Trial Update: Using Learning Teams for Reflective Adaptation for Diabetes and Depression [NA]
A completed clinical trial evaluating the use of learning teams to support reflective adaptation in diabetes and depression care.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression
A completed observational study examining whether late-onset depression is associated with cardiovascular disease, including coronary artery…